Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | ACHE | P22303 | 5/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12392802 | 0.94 | ACHE (0.43) | TDP1ALDH1A1MAPTACHESMN1; SMN2 | |
| SCHEMBL1415617 | 0.85 | SLC6A3 (0.49) | ALDH1A1MAPTACHENPC1RAB9A | |
| SCHEMBL1415465 | 0.85 | MEN1 (0.49) | ALDH1A1MAPTACHESMN1; SMN2NPC1 | |
| SCHEMBL1415795 | 0.85 | ACHE (0.44) | TDP1ALDH1A1MAPTACHEHPGD | |
| SCHEMBL1415808 | 0.85 | HTT (0.54) | TDP1ALDH1A1MAPTACHESMN1; SMN2 | |
| SCHEMBL3909905 | 0.84 | MAPT (0.53) | ALDH1A1MAPTACHESMN1; SMN2NPC1 | |
| SCHEMBL1415514 | 0.82 | AKR1C3 (0.46) | TDP1ALDH1A1MAPTSMN1; SMN2NPC1 | |
| SCHEMBL3905197 | 0.82 | SLC6A3 (0.52) | MAPTACHESMN1; SMN2NPC1RAB9A | |
| SCHEMBL3902803 | 0.82 | MAPT (0.45) | TDP1ALDH1A1MAPTSMN1; SMN2NPC1 | |
| SCHEMBL3899783 | 0.81 | EPHX2 (0.45) | TDP1ALDH1A1ACHENPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4582498-A1 | PRINTING INK SET, PRINTED MATTER, AND PACKAGING MATERIAL | Artience Co., Ltd. (JP) | 2025-07-09 | — | — | EP | disclosed |
| WO-2024048522-A1 | PRINTING INK SET, PRINTED MATTER, AND PACKAGING MATERIAL | ａｒｔｉｅｎｃｅ株式会社 | 2024-03-07 | — | — | WO | disclosed |
| WO-2023210260-A1 | PRINTING INK SET, PRINTED MATTER, AND PACKAGING MATERIAL | 東洋インキＳＣホールディングス株式会社 | 2023-11-02 | — | — | WO | disclosed |
| US-7947761-B2 | Inkjet ink compositions comprising polymeric dispersants having attached chromophore groups | CABOT CORPORATION (US) | 2011-05-24 | — | — | US | disclosed |
| EP-1399742-B1 | QUINACRIDONE LABELLING REAGENTS FOR FLUORESCENCE DETECTION OF BIOLOGICAL MATERIALS | GE HEALTHCARE UK LTD (GB) | 2011-03-16 | — | — | EP | disclosed |
| EP-0632106-B2 | Process for the production of 2,5-di(arylamino)-3,6- dihydroterephthalic acid dialkyl ester, and process for the production of quinacridone from said ester as intermediate | TOYO INK MFG CO (JP) | 2009-02-25 | — | — | EP | disclosed |
| US-20090017307-A1 | Process for the Preparation of Organic Materials | MCA TECHNOLOGIES, GMBH (CH) | 2009-01-15 | — | — | US | disclosed |
| US-20090017307-A1 | Process for the Preparation of Organic Materials | MCA TECHNOLOGIES, GMBH (CH) | 2009-01-15 | — | — | US | disclosed |
| US-20080060554-A1 | Process for the Preparation of Organic Materials | MCA TECHNOLOGIES, GMBH (CH) | 2008-03-13 | — | — | US | disclosed |
| US-20080060554-A1 | Process for the Preparation of Organic Materials | MCA TECHNOLOGIES, GMBH (CH) | 2008-03-13 | — | — | US | disclosed |
| US-5659036-A | Process for the production of 2,5-di(arylamino)-3,6-dihydroterephthalic acid dialkyl ester, and process for the production of quinacridone from said ester as intermediate | TOYO INK MANUFACTURING CO., LTD. (JP) | 1997-08-19 | — | — | US | disclosed |
| US-5610306-A | ALCOHOL ELIMINATION REACTION OF 2,5-DI(PHENYLAMINO)-3,6--DIHYDROTEREPHTHALIC ACID DIALKYL ESTER; CYCLIZATION | TOYO INK MANUFACTURING CO., LTD. (JP) | 1997-03-11 | — | — | US | disclosed |
| EP-0654472-A1 | Process for the production of 6,13-dihydroquinacridones and apparatus for use for the production | TOYO INK MANUFACTURING CO., LTD. (JP) | 1995-05-24 | — | — | EP | disclosed |
| EP-0632106-A1 | Process for the production of 2,5-di(arylamino)-3,6- dihydroterephthalic acid dialkyl ester, and process for the production of quinacridone from said ester as intermediate | TOYO INK MANUFACTURING CO., LTD. (JP) | 1995-01-04 | — | — | EP | disclosed |
| US-5367096-A | Process for the preparation of 2,5-di(phenylamino)terephthalic acid and dialkyl esters thereof in high purity | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-11-22 | — | — | US | disclosed |
| US-5347038-A | Starting material for quinacridone pigments, pollution control, from succinic acid diester and aniline | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-09-13 | — | — | US | disclosed |
| EP-0363756-B1 | METHOD FOR THE PREPARATION OF 2,5-DIARYLAMINO-TEREPHTHALIC ACIDS | BAYER AG (DE) | 1992-12-02 | — | — | EP | disclosed |
| US-4981997-A | Process for the preparation of 2,5-diarylaminoterephthalic acids | BAYER AKTIENGESELLSCHAFT (DE) | 1991-01-01 | — | — | US | disclosed |
| US-4758664-A | Process for the preparation of linear quinacridones | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-07-19 | — | — | US | disclosed |
| EP-0204139-A2 | Process for the manufacture of linear quinacridones | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-12-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090017307-A1 | Process for the Preparation of Organic Materials | KLK4, PDK4, GRK1 | TDP1 353/4885ALDH1A1 431/4885MAPT 687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.